Norwich Eaton's Asacol (mesalamine)
"Approvable" as of Oct. 10. Approval of the drug is being sought for induction and maintenance of remission of ulcerative colitis....Hoechst-Roussel's Metane (velnacrine): Company is now concentrating on an NDA filing for the Alzheimer's drug with the objective of submitting the application to FDA by the end of this year. The firm had expressed interest earlier this year in submitting a Treatment IND request ("The Pink Sheet" July 22, p. 8)....
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth